|
|
|
|
| LEADER |
01300 am a22001573u 4500 |
| 001 |
384273 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Street, Duncan
|e author
|
| 700 |
1 |
0 |
|a Halfpenny, Christopher A.
|e author
|
| 700 |
1 |
0 |
|a Galea, Ian
|e author
|
| 245 |
0 |
0 |
|a CNS inflammation other than multiple sclerosis: how likely is diagnosis?
|
| 260 |
|
|
|c 2014-04-01.
|
| 856 |
|
|
|z Get fulltext
|u https://eprints.soton.ac.uk/384273/1/__soton.ac.uk_ude_personalfiles_users_ig1_mydesktop_Street%2520D%2520et%2520al%25202014.pdf
|
| 520 |
|
|
|a The incidence, diagnostic landscape, and workload impact of CNS inflammatory diseases other than multiple sclerosis (MS) (CIDOMS) in a tertiary setting is unknown. We describe a retrospective case series of 64 patients identified over a 2-year period (2009-2010) at the Wessex Neurological Centre in the United Kingdom, accounting for 4% of all patients seen at the center. As expected, neurosarcoidosis and neuromyelitis optica (NMO) were the most common diagnoses reached (14% each); other diagnoses singly accounted for <10%. However, the likeliest diagnostic outcome (strikingly, in 25%) was nondiagnosis, despite intensive investigation and a mean follow-up period of 3 years. Undiagnosed patients with CIDOMS represented the largest workload of the neurology center
|
| 540 |
|
|
|a cc_by_4
|
| 655 |
7 |
|
|a Article
|
